Past Events

PhD upgrade | Should empirical oral antibiotics remain part of TB diagnostic algorithms in the era of antimicrobial stewardship?

Summary Antimicrobial resistance (AMR) is a growing public health threat which is in part fueled by empirical antibiotic usage. However, to complement suboptimal diagnostics for Tuberculosis(TB), the leading cause of infectious disease mortality, standard diagnostic algorithms include empirical antibiotic use. The antibiotic course, referred to as “trial-of-antibiotics” and given to mycobacteriology negative but symptomatic adults, […]

PhD Upgrade | Exploring the effectiveness, acceptability, and equity of access of rapid diagnostic tests for AMR in hospitals in the UK

Summary Developing and implementing rapid diagnostic tests (RDTs) to detect antimicrobial resistance (AMR) in bacterial pathogens is a priority area for the Department of Health and the National Institute for Health Research. RDTs are faster than laboratory-based culture and antibiotic susceptibility testing, allowing prescribers to switch patients onto appropriate antibiotic therapy more quickly than traditional […]

Seminar | The new Sustainable Development Goals and Access to Essential Medicines

Summary The Honourable Michael Kirby AC CMG will deliver this special Seminar entitled ‘The new Sustainable Development Goals and Access to Essential Medicines’. First appointed a judge in 1975, he ultimately served on the High Court of Australia, the nation’s Federal Supreme Court, 1996-2009. Since his retirement from judicial office in 2009, he has literally […]

Seminar | Timeline sampling of individual patients reveals 
positive selection and co-selection of antibiotic resistance

Co-hosted between the AMR Centre and CMMID Centre Summary Antibiotic resistant bacteria of the Enterobacteriaceae family are a major threat to public health. Enterobacteriaceae are common, gram-negative members of the human gut microbiota who can turn into life-threatening blood infections that require treatment with antibiotics. In a recent worldwide endemic of the CTX-m resistance gene, […]

Seminar | New antibiotics, but not enough solutions – CANCELLED

Details Speaker: Neil Woodford, Public Health England Date: 6 March 2018 – CANCELLED Time: 12:45 – 14:00 Venue: Jerry Morris B, Tavistock Place

Seminar | The role of host and pathogen population structure in the dynamics of drug and multi-drug resistance

Summary Understanding the short- and long-term dynamics of drug and multi-drug resistance is important for public health. Yet, there are pervasive trends in resistance dynamics that have not been fully explained. Firstly, antibiotic sensitive and resistant strains coexist robustly, despite prolonged selection pressure from antibiotics. Secondly, resistance to different antibiotics tends to co-occur on the same […]

ITD seminar | Acinetobacter and AMR

Summary Dr Wareham is a clinical microbiologist with particular interests in infection control and antibiotic stewardship in intensive care unit. They apply a range of methodologies, including genomics, molecular biology, in vitro and in vivo models, and analysis of epidemiological and clinical data in areas such as outbreak characterisation, surveillance, diagnostic evaluation and assessment of […]

APPG | How to incentivise the development of antibiotics: lessons from malaria drug research partnerships

All-Party Parliamentary Group on Malaria & Neglected Tropical Diseases This is a joint event between the APPG on Antibiotics and the APPG on Malaria & NTDs Chaired by Julian Sturdy MP and Jeremy Lefroy MP   Guest speakers    Dr David Reddy, Chief Executive Officer of Medicines for Malaria Venture: Incentivising drug discovery: what have […]

PHP PhD Upgrading | Exploring the effectiveness, acceptability, and equity of access of rapid diagnostic tests for antimicrobial resistance in hospitals in the United Kingdom

Speaker: Rebecca Glover Supervisors: Mark Petticrew, Sharon Peacock Dept: PHES Date: Monday 26th February Time: 2.30pm Venue: G1, Jenny Roberts Room, Tavistock Place   ***ALL WELCOME***

Seminar | Which government policies actually reduce human antimicrobial use?

Summary As governments face domestic and international pressure to tackle antimicrobial resistance (AMR), policy strategies such as regulating antimicrobial sales and restricting use of last-resort drugs have become key strategies to reduce antimicrobial use. To inform future action, governments should have access to synthesized data on the effectiveness of large-scale AMR interventions. We have conducted […]